Annual CFI
$1.95 M
-$6.58 M-77.18%
31 December 2023
Summary:
Yield10 Bioscience annual cash flow from investing activities is currently $1.95 million, with the most recent change of -$6.58 million (-77.18%) on 31 December 2023. During the last 3 years, it has risen by +$2.59 million (+401.55%). YTEN annual CFI is now -93.80% below its all-time high of $31.38 million, reached on 31 December 2010.YTEN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
$0.000.00%
30 June 2024
Summary:
Yield10 Bioscience quarterly cash flow from investing activities is currently $0.00, unchanged on 30 June 2024. Over the past year, it has dropped by -$1000.00 (-100.00%). YTEN quarterly CFI is now -100.00% below its all-time high of $17.27 million, reached on 31 March 2008.YTEN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$19.00 K
+$18.00 K+48.65%
30 June 2024
Summary:
Yield10 Bioscience TTM cash flow from investing activities is currently -$19.00 thousand, with the most recent change of +$18.00 thousand (+48.65%) on 30 June 2024. Over the past year, it has dropped by -$3.48 million (-100.55%). YTEN TTM CFI is now -100.05% below its all-time high of $38.89 million, reached on 31 March 2013.YTEN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YTEN Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -77.2% | -100.0% | -100.5% |
| 3 y3 years | +401.6% | -100.0% | -100.4% |
| 5 y5 years | +169.8% | -100.0% | -100.4% |
YTEN Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -77.2% | +142.5% | -100.0% | +100.0% | -100.2% | +99.7% |
| 5 y | 5 years | -77.2% | +142.5% | -100.0% | +100.0% | -100.2% | +99.8% |
| alltime | all time | -93.8% | +102.0% | -100.0% | +100.0% | -100.0% | +100.0% |
Yield10 Bioscience Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $0.00(0.0%) | -$19.00 K(-48.6%) |
| Mar 2024 | - | $0.00(-100.0%) | -$37.00 K(-101.9%) |
| Dec 2023 | $1.95 M(-77.2%) | -$20.00 K(-2100.0%) | $1.95 M(-43.9%) |
| Sept 2023 | - | $1000.00(-105.6%) | $3.46 M(-50.2%) |
| June 2023 | - | -$18.00 K(-100.9%) | $6.96 M(-34.3%) |
| Mar 2023 | - | $1.98 M(+32.1%) | $10.59 M(+24.3%) |
| Dec 2022 | $8.52 M(-286.2%) | $1.50 M(-57.1%) | $8.52 M(+3863.7%) |
| Sept 2022 | - | $3.49 M(-3.4%) | $215.00 K(-109.5%) |
| June 2022 | - | $3.62 M(-4209.1%) | -$2.27 M(-66.1%) |
| Mar 2022 | - | -$88.00 K(-98.7%) | -$6.70 M(+46.3%) |
| Dec 2021 | -$4.58 M(+609.8%) | -$6.81 M(-776.6%) | -$4.58 M(-197.2%) |
| Sept 2021 | - | $1.01 M(-224.7%) | $4.71 M(+4030.7%) |
| June 2021 | - | -$807.00 K(-139.8%) | $114.00 K(-90.3%) |
| Mar 2021 | - | $2.03 M(-18.1%) | $1.17 M(-281.4%) |
| Dec 2020 | -$645.00 K(-78.6%) | $2.48 M(-169.1%) | -$645.00 K(-92.7%) |
| Sept 2020 | - | -$3.59 M(-1541.4%) | -$8.87 M(+107.0%) |
| June 2020 | - | $249.00 K(+15.8%) | -$4.29 M(-22.7%) |
| Mar 2020 | - | $215.00 K(-103.7%) | -$5.55 M(+83.9%) |
| Dec 2019 | -$3.02 M(+8.1%) | -$5.75 M(-675.5%) | -$3.02 M(-167.3%) |
| Sept 2019 | - | $999.00 K(-198.8%) | $4.48 M(-18.1%) |
| June 2019 | - | -$1.01 M(-136.8%) | $5.47 M(+38.3%) |
| Mar 2019 | - | $2.75 M(+57.3%) | $3.95 M(-241.8%) |
| Dec 2018 | -$2.79 M(>+9900.0%) | $1.75 M(-12.1%) | -$2.79 M(-38.5%) |
| Sept 2018 | - | $1.99 M(-178.6%) | -$4.53 M(-30.5%) |
| June 2018 | - | -$2.53 M(-36.8%) | -$6.53 M(+63.1%) |
| Mar 2018 | - | -$3.99 M(<-9900.0%) | -$4.00 M(>+9900.0%) |
| Dec 2017 | -$6000.00(-100.1%) | $0.00(-100.0%) | -$6000.00(-83.8%) |
| Sept 2017 | - | -$6000.00(<-9900.0%) | -$37.00 K(-100.4%) |
| Mar 2017 | - | $0.00(-100.0%) | $10.22 M(+4.8%) |
| Dec 2016 | $9.75 M(-1688.3%) | -$31.00 K(-100.3%) | $9.75 M(+1.3%) |
| Sept 2016 | - | $10.45 M(-5403.6%) | $9.63 M(-999.7%) |
| June 2016 | - | -$197.00 K(-57.9%) | -$1.07 M(+12.0%) |
| Mar 2016 | - | -$468.00 K(+200.0%) | -$955.00 K(+55.5%) |
| Dec 2015 | -$614.00 K(-105.3%) | -$156.00 K(-37.3%) | -$614.00 K(+326.4%) |
| Sept 2015 | - | -$249.00 K(+203.7%) | -$144.00 K(-376.9%) |
| June 2015 | - | -$82.00 K(-35.4%) | $52.00 K(-99.3%) |
| Mar 2015 | - | -$127.00 K(-140.4%) | $6.95 M(-40.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | $11.67 M(-41.0%) | $314.00 K(-692.5%) | $11.67 M(-29.8%) |
| Sept 2014 | - | -$53.00 K(-100.8%) | $16.63 M(-15.0%) |
| June 2014 | - | $6.81 M(+48.2%) | $19.57 M(+96.7%) |
| Mar 2014 | - | $4.60 M(-12.7%) | $9.95 M(-49.7%) |
| Dec 2013 | $19.79 M(-20.9%) | $5.27 M(+82.5%) | $19.79 M(+4.1%) |
| Sept 2013 | - | $2.89 M(-202.8%) | $19.00 M(-31.3%) |
| June 2013 | - | -$2.81 M(-119.4%) | $27.67 M(-28.9%) |
| Mar 2013 | - | $14.44 M(+222.1%) | $38.89 M(+55.4%) |
| Dec 2012 | $25.02 M(-380.8%) | $4.48 M(-61.2%) | $25.02 M(-24.3%) |
| Sept 2012 | - | $11.55 M(+37.3%) | $33.03 M(+22.7%) |
| June 2012 | - | $8.41 M(+1368.1%) | $26.93 M(-206.9%) |
| Mar 2012 | - | $573.00 K(-95.4%) | -$25.18 M(+182.7%) |
| Dec 2011 | -$8.91 M(-128.4%) | $12.49 M(+129.4%) | -$8.91 M(-41.6%) |
| Sept 2011 | - | $5.45 M(-112.5%) | -$15.26 M(+12.9%) |
| June 2011 | - | -$43.70 M(-359.4%) | -$13.51 M(-137.5%) |
| Mar 2011 | - | $16.85 M(+174.0%) | $36.01 M(+14.8%) |
| Dec 2010 | $31.38 M(-266.4%) | $6.15 M(-14.5%) | $31.38 M(+956.5%) |
| Sept 2010 | - | $7.19 M(+23.6%) | $2.97 M(-14.3%) |
| June 2010 | - | $5.82 M(-52.4%) | $3.46 M(-241.6%) |
| Mar 2010 | - | $12.21 M(-154.9%) | -$2.45 M(-87.0%) |
| Dec 2009 | -$18.86 M(-189.4%) | -$22.26 M(-389.5%) | -$18.86 M(-415.2%) |
| Sept 2009 | - | $7.69 M(-8548.4%) | $5.98 M(-38.9%) |
| June 2009 | - | -$91.00 K(-97.8%) | $9.79 M(-2683.4%) |
| Mar 2009 | - | -$4.19 M(-262.6%) | -$379.00 K(-101.8%) |
| Dec 2008 | $21.09 M(+263.4%) | $2.58 M(-77.6%) | $21.09 M(-10.9%) |
| Sept 2008 | - | $11.50 M(-212.0%) | $23.68 M(-2.7%) |
| June 2008 | - | -$10.26 M(-159.4%) | $24.34 M(-2.6%) |
| Mar 2008 | - | $17.27 M(+234.3%) | $24.98 M(+330.3%) |
| Dec 2007 | $5.80 M(-106.0%) | $5.17 M(-57.5%) | $5.80 M(-106.6%) |
| Sept 2007 | - | $12.15 M(-226.3%) | -$87.51 M(-19.2%) |
| June 2007 | - | -$9.62 M(+407.5%) | -$108.33 M(+29.7%) |
| Mar 2007 | - | -$1.90 M(-97.8%) | -$83.54 M(-13.9%) |
| Dec 2006 | -$97.08 M(+4995.9%) | -$88.15 M(+917.7%) | -$97.08 M(+987.2%) |
| Sept 2006 | - | -$8.66 M(-157.1%) | -$8.93 M(+3231.7%) |
| June 2006 | - | $15.17 M(-198.3%) | -$268.00 K(-98.3%) |
| Mar 2006 | - | -$15.43 M | -$15.43 M |
| Dec 2005 | -$1.91 M(-39.0%) | - | - |
| Dec 2004 | -$3.12 M | - | - |
FAQ
- What is Yield10 Bioscience annual cash flow from investing activities?
- What is the all time high annual CFI for Yield10 Bioscience?
- What is Yield10 Bioscience annual CFI year-on-year change?
- What is Yield10 Bioscience quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Yield10 Bioscience?
- What is Yield10 Bioscience quarterly CFI year-on-year change?
- What is Yield10 Bioscience TTM cash flow from investing activities?
- What is the all time high TTM CFI for Yield10 Bioscience?
- What is Yield10 Bioscience TTM CFI year-on-year change?
What is Yield10 Bioscience annual cash flow from investing activities?
The current annual CFI of YTEN is $1.95 M
What is the all time high annual CFI for Yield10 Bioscience?
Yield10 Bioscience all-time high annual cash flow from investing activities is $31.38 M
What is Yield10 Bioscience annual CFI year-on-year change?
Over the past year, YTEN annual cash flow from investing activities has changed by -$6.58 M (-77.18%)
What is Yield10 Bioscience quarterly cash flow from investing activities?
The current quarterly CFI of YTEN is $0.00
What is the all time high quarterly CFI for Yield10 Bioscience?
Yield10 Bioscience all-time high quarterly cash flow from investing activities is $17.27 M
What is Yield10 Bioscience quarterly CFI year-on-year change?
Over the past year, YTEN quarterly cash flow from investing activities has changed by -$1000.00 (-100.00%)
What is Yield10 Bioscience TTM cash flow from investing activities?
The current TTM CFI of YTEN is -$19.00 K
What is the all time high TTM CFI for Yield10 Bioscience?
Yield10 Bioscience all-time high TTM cash flow from investing activities is $38.89 M
What is Yield10 Bioscience TTM CFI year-on-year change?
Over the past year, YTEN TTM cash flow from investing activities has changed by -$3.48 M (-100.55%)